Sai Life Sciences Limited has scheduled a meeting of its Board of Directors for May 14, 2026. The primary agenda for the meeting includes the review and approval of the company’s audited standalone and consolidated financial results for the fourth quarter and the full fiscal year ended March 31, 2026.
Board Meeting Schedule
The management of Sai Life Sciences has confirmed that its Board of Directors will convene on Thursday, May 14, 2026. The purpose of this assembly is to evaluate the company’s performance for the quarter and the entire 2025-26 fiscal year.
Financial Reporting
During the session, the board will deliberate on both standalone and consolidated financial statements for the period ending March 31, 2026. This reporting provides key insights into the company’s operational health and growth trajectories achieved throughout the final quarter of the fiscal year.
Trading Window Restrictions
In accordance with internal compliance protocols, the company has implemented a temporary suspension of trading for designated persons and their immediate relatives. This trading window closure commenced on April 1, 2026, and is scheduled to remain in effect until 48 hours following the official release of the financial results to the public.
Source: BSE
